Relevant and even prescient commentary on news, politics and the economy.

Jobless claims: only one week’s data, but cause for significant concern

Jobless claims: only one week’s data, but cause for significant concern   Today marked the biggest increase in new jobless claims in two months, and one of the two biggest increases since May, while the slightly lagging continuing claims continued to decline. On a non-seasonally adjusted basis, new jobless claims rose by 76,670 to 885,885. […]

Consumer prices rise a “normal” 0.2% in September

Consumer prices rise a “normal” 0.2% in September In September Consumer prices rose a “normal” 0.2%, the first such typical increase since the pandemic began (blue in the graph below): For the past 40 years, recessions had typically happened when CPI less energy costs (red) had risen to close to or over 3%/year. We are […]

College educational attainment by age demographic

College educational attainment by age demographic   There is no economic data today due to the Columbus Day observance. So let me drop this graph of a metric I have been trying to find, of college educational attainment by age demographic, that I finally came across a couple of days ago: It is commonplace that […]

August JOLTS report conforms to prior early recession recovery pattern

August JOLTS report conforms to prior early recession recovery pattern   Yesterday’s JOLTS report for August showed a jobs market that is still just beginning to mend. Hires were up, and layoffs and discharges were down, which is good, but job openings and voluntary quits both declined. We are far enough along past the worst […]

claims: yet another week of glacial progress

Jobless claims: yet another week of glacial progress   Today marked yet another week of glacial progress in initial jobless claims, at levels worse than the worst weekly levels of the Great Recession. On a non-seasonally adjusted basis, new jobless claims rose by 5,312 to 804,307. After seasonal adjustment (which is far less important than […]

Just Stirring the Pot – Updated

Regeneron Seeks Emergency Approval per trump’s miracle recovery and subsequent endorsement. Biotech company Regeneron moved Wednesday to apply for emergency approval for an experimental antibody treatment praised by President Trump. “Subsequent to our discussions with regulatory authorities, we have submitted a request to the U.S. Food and Drug Administration for an Emergency Use Authorization (EUA) […]

To Do IV. Education

The COVID-19 pandemic is just what the Doctor ordered for American education. Well, it could be. First, we must, as is our wont, muddle for as long as possible. Plenty of time. What with students and teachers being quarantined one right after another, it’s going to be a long year. Time a plenty to fall […]